Caprock Group, Inc. Sera Prognostics, Inc. Transaction History
Caprock Group, Inc.
- $4.08 Billion
- Q3 2025
A detailed history of Caprock Group, Inc. transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 33,523 shares of SERA stock, worth $90,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,523
Previous 33,523
-0.0%
Holding current value
$90,176
Previous $123,000
17.07%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SERA
# of Institutions
67Shares Held
22.4MCall Options Held
12.3KPut Options Held
100-
Baker Bros. Advisors LP New York, NY5.5MShares$14.8 Million0.15% of portfolio
-
Whetstone Capital Advisors, LLC Shawnee Mission, KS3.63MShares$9.77 Million3.67% of portfolio
-
Interwest Venture Management CO2.42MShares$6.5 Million21.78% of portfolio
-
Abrdn PLC2.28MShares$6.13 Million0.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$4.44 Million0.97% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $79.6M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...